BrainCheck Secures $13M to Scale AI-Powered Cognitive Care Platform

Event summary

  • BrainCheck raised $13 million in Series A funding led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises.
  • The capital will expand enterprise cognitive care infrastructure, including deeper workflow integration and longitudinal patient monitoring.
  • BrainCheck partners with collaborative care organizations to operationalize cognitive care delivery in practices lacking staffing or infrastructure.
  • The platform is used by over 500 healthcare organizations, with more than 640,000 cognitive assessments completed.
  • BrainCheck’s strategy focuses on structured cognitive care pathways, earlier identification of cognitive risk, and AI-assisted population health analysis.

The big picture

BrainCheck’s funding comes as cognitive health becomes a priority in aging populations and value-based care models gain traction. The company’s platform addresses a critical gap in early identification and longitudinal management of cognitive impairment, positioning it as a key player in the evolving healthcare landscape. With over 500 healthcare organizations using its tools, BrainCheck is well-positioned to capitalize on the shift toward standardized, scalable cognitive care solutions.

What we're watching

Market Adoption
How BrainCheck will scale its platform across primary care and specialty settings, and whether it can maintain momentum with existing and new healthcare partners.
Regulatory Compliance
The pace at which BrainCheck integrates AI-assisted clinical infrastructure while ensuring compliance with healthcare regulations and maintaining clinician-directed decision-making.
Competitive Positioning
Whether BrainCheck can differentiate itself in a growing market of digital cognitive assessment tools and sustain its lead with advanced AI and population-scale deployment.

Related topics

Technology Expansion